2 insiders bought €115k of shares over the last 90 days, the latest filed 22 Sept 2026.
Cluster: 2 buyers in 30 daysVillage Farms International, Inc. belongs to the Food & Agriculture sector. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Village Farms International, Inc. logged 74 filings by 22 insiders.
Purchases and sales both appear in the filings: 8 purchases (4 insiders, €243k) and 4 sales (2 insiders, €591k). The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 senior executives and 1 chief executive. Bovenschen Orville filed the largest sale, €220k, on 3 December 2025.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase is recent: it was published 25 days ago, on 22 September 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade.
Compared with its exchange (5,810 companies, median 19 filings), a count of 74 filings is above the norm. Looking back to 2022, when coverage begins, insiders filed 21 purchases and 8 sales. The 10-K for the year ended 31 December 2025 shows 215.9 m USD of revenue and 32.4 m USD of net income.
Elsewhere in the same sector, our signals recently picked up insider purchases at Orkla ASA and Alto Ingredients, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
+1 other insider
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Village Farms International, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$5.83.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 96 declarations
Village Farms International, Inc. is a United States-listed company traded on NASDAQ, with roots in large-scale controlled-environment agriculture. The business was originally built as a greenhouse vegetable producer and has since evolved into a more diversified platform focused primarily on regulated cannabis, hemp-derived CBD, and selected plant-based consumer products. While the company’s operating footprint is heavily associated with Vancouver, British Columbia, its equity listing and corporate context are U.S.-based, which is important for investors following SEC Form 4 insider activity and U.S. market disclosures. ([villagefarms.com](https://villagefarms.com/?utm_source=openai))
From an investment perspective, the main story is strategic transformation. Village Farms leverages decades of greenhouse experience, scale, and vertically integrated agricultural know-how to compete in higher-growth cannabinoid markets. Historically, the company supplied fresh produce, especially tomatoes and other vegetables, to grocery and large-format retail customers in the United States and Canada. Over time, management has shifted the portfolio toward cannabis and hemp-related businesses, while retaining a greenhouse platform that remains a core competitive asset. ([villagefarms.com](https://villagefarms.com/?utm_source=openai))
The most important operating asset is Pure Sunfarms, the company’s wholly owned Canadian cannabis subsidiary. Village Farms describes it as one of the world’s largest cannabis operations and among Canada’s lowest-cost greenhouse producers, with a strong brand position in the domestic market. The group also owns Rose LifeScience in Quebec, which supports commercialization and market access in that province. In the United States, Village Farms maintains a hemp/CBD platform through CBDistillery, one of the better-known CBD brands in the country, though U.S. high-THC cannabis remains constrained by federal legality and regulatory uncertainty. ([villagefarms.com](https://villagefarms.com/about/?utm_source=openai))
Geographically, the company’s footprint spans Canada, the United States, and the Netherlands, with additional greenhouse capacity available for future expansion in Canada and a meaningful greenhouse presence in West Texas. That geographic spread gives Village Farms optionality: it can serve regulated cannabis markets in Canada, build international export channels, and preserve upside for potential U.S. market opening over time. Its competitive position is therefore based on scale, cost discipline, controlled cultivation, and the ability to move product across regulated channels rather than on brand alone. ([villagefarms.com](https://villagefarms.com/about/?utm_source=openai))
Recent developments reinforce a more focused and financially disciplined profile. In 2025, Village Farms closed the transaction to privatize most of its fresh produce business, effectively turning the company into a more concentrated cannabis and cannabinoid platform with residual exposure to produce-related assets. In August 2025, it announced an additional 550,000 square feet of cannabis conversion capacity in Delta, British Columbia, implying further production growth into 2026 and beyond. In March 2026, management reported record full-year 2025 profitability and also amended and extended its Farm Credit Canada loan, improving the rate and pushing maturity to 2031. Taken together, these actions point to a company prioritizing profitability, balance-sheet flexibility, and operating leverage. ([news.villagefarms.com](https://news.villagefarms.com/news-releases/news-release-details/village-farms-international-announces-closing-transaction?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 11 filings published between 25 August and 22 September 2026: 4 open-market purchases by insiders for €197k. 7 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: DEGIGLIO MICHAEL A (Chief Executive Officer), purchases of €88k; DeGiglio, Michael Anthony (4 - Director of Issuer, 5 - Senior Officer of Issuer), purchases of €63k; Woodward Christopher C. (Director), purchases of €27k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 215.9 m USD | 32.4 m USD | 0.27 USD | 10-K |
| Dec 2024 | 195.9 m USD | -35.9 m USD | -0.32 USD | 10-K |
| Dec 2023 | 163.1 m USD | -34.8 m USD | -0.32 USD | 10-K |
| Dec 2022 | 293.6 m USD | -101.1 m USD | -1.13 USD | 10-K |
| Dec 2021 | 268.0 m USD | -9.1 m USD | -0.11 USD | 10-K/A |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.